Ayla Ellison

In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in peer countries, according to an AARP Public Policy Institute

Boston remains biotech's most influential hub, but the questions facing the region are increasingly global.

What does the Department of Health & Human Services' Office of Inspector General do ? Today, Senior Writer Anastassia Gliadkovskaya sits down with Assistant Regional Inspector General Scott Perry to find out.

Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s ann

Resmed has closed its $340 million acquisition of Noctrix Health, picking up a wearable neuromodulation device that pushes the sleep tech giant beyond its core sleep apnea and respiratory care busi

A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in a randomized trial, adding new fuel to the industry’s push to bring CGM

As healthcare costs rise and access challenges persist, health plans face growing pressure to engage members more effectively.

Fierce Biotech is returning to the U.K. in November for a day of curated discussions and networking at The Savoy, London’s iconic hotel.

In this episode of “The Top Line,” recorded on site at Fierce Biotech Week in Boston, Fierce's Ayla Ellison sits down with Christelle Huguet, Ph.D., executive

Life insurance may not be the first thing that comes to mind when thinking about healthcare. But some life insurers are increasingly interested in incentivizing healthy habits.